For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Clinical Immunoanalyzer detect and quantify specific analytes in blood or in samples of body fluids by utilizing immunoassay methodologies such as immunoprecipitation, particle immunoassays, immunonephelometry, radioimmunoassay, enzyme immunoassay, fluorescent immunoassay, and chemiluminescent immunoassays.
Scope of the Report:
This report focuses on the Clinical Immunoanalyzer in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The global average price of clinical immunoanalyzer is in the decrease trend, from 19.36 K USD/Unit in 2012 to 19.19 K USD/Unit in 2016.
The classification of Clinical immunoanalyzer includes CLIA, ELISA, RIA, FIA and Other, and the proportion of CLIA in 2016 is about 46%, and the proportion is in increasing trend from 2012 to 2016.
Clinical immunoanalyzer is widely used in Hospital, Clinic and Other Institutions. The most proportion of clinical immunoanalyzer is used in Hospital, and the consumption proportion is about 72%.
North America is the largest consumption place, with a consumption market share nearly 36% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 27%.
Market competition is intense. Roche Diagnostics, Abbott, Siemens, Beckman Coulter, Ortho-Clinical Diagnostics etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Clinical Immunoanalyzer is expected to grow at a CAGR of roughly 5.6% over the next five years, will reach 5200 million US$ in 2023, from 3740 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Roche Diagnostics
- Beckman Coulter
- Ortho-Clinical Diagnostics
- Werfen Life
- Thermo Fisher Scientific
- Tosoh Corporation
- Randox Laboratories
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
There are 15 Chapters to deeply display the global Clinical Immunoanalyzer market.
Chapter 1, to describe Clinical Immunoanalyzer Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Clinical Immunoanalyzer, with sales, revenue, and price of Clinical Immunoanalyzer, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Clinical Immunoanalyzer, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Clinical Immunoanalyzer market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Clinical Immunoanalyzer sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source